Table. 1.

General characteristics of the participants

Variable Total (n=9,545) Male (n=3,749) Female (n=5,796)
Age (y) 42.1±11.2 44.2±11.3 40.7±10.9
Body mass index (kg/m2) 20.8±1.5 21.3±1.4 20.5±1.6
Muscle mass (kg) 41.1±7.4 48.9±4.7 36.1±3.4
Body fat mass (kg) 13.6±3.5 11.8±3.0 14.8±3.2
MMD (kg) 3.9±2.6 4.1±3.0 3.7±2.4
Waist circumference (cm) 72.9±6.6 77.2±5.2 70.0±5.8
Systolic blood pressure (mmHg) 117.2±13.7 122.1±13.0 114.0±13.3
Diastolic blood pressure (mmHg) 71.5±9.9 74.5±9.8 69.5±9.5
Total cholesterol (mg/dL) 183.8±31.4 185.7±31.9 182.5±30.9
Triglyceride (mg/dL) 94.2±56.1 110.1±64.0 84.0±47.5
HDL-C (mg/dL) 58.9±13.8 53.7±12.6 62.2±13.6
LDL-C (mg/dL) 109.9±30.0 116.0±31.0 105.9±28.6
AST (IU/L) 23.2±19.0 25.8±22.0 21.5±16.5
ALT (IU/L) 20.2±23.0 25.4±34.0 16.8±9.8
γ-GTP (IU/L) 24.1±50.4 35.7±69.0 16.6±30.9
Fasting plasma glucose (mg/dL) 85.0±8.5 86.7±9.0 83.9±8.0
HbA1c (%) 5.3±0.3 5.3±0.3 5.3±0.3
hsCRP >0.2 mg/dL (%) 607 (7.2) 290 (7.7) 317 (5.5)
HOMA-IR ≥2.5 (%) 100 (5.5) 19 (3.2) 81 (6.7)
Current smoking (%) 1,421 (14.9) 1,312 (35.0) 109 (1.9)
Regular exercise (%) 5,135 (53.8) 2,067 (55.1) 3,068 (52.9)
Alcohol drinking (%) 3,898 (40.8) 2,106 (56.2) 1,790 (30.9)
Fatty liver (%) 1,266 (13.3) 799 (21.3) 467 (8.1)
MAFLD (%) 519 (5.4) 334 (8.9) 185 (3.2)

Data are shown as mean±standard deviation for continuous variables and number (%) for categorical variables.

MMD, muscle mass deficit; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, gamma-glutamyl transferase; HbA1c, glycated hemoglobin; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance; MAFLD, metabolic dysfunction-associated fatty liver disease.

Korean J Fam Pract 2023;13:171~178 https://doi.org/10.21215/kjfp.2023.13.3.171
© KJFP